Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Serial magnetic resonance imaging representation in a Baló's concentric sclerosis.
Increased Affinity of JC Polyomavirus Capsid for LSTc Over Other Sialylated Glycans Is a Major Determinant of Infectivity.
Oropharyngeal dysphagia in multiple sclerosis.
Cortical Thinning Correlates with Cognitive Change in Multiple Sclerosis but not in Neuromyelitis Optica.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Axon regeneration impediment: the role of paired immunoglobulin-like receptor B.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Regulation of Immunity by Butyrophilins.
Quality of Life, Cognition and Mood in Adults with Pediatric Multiple Sclerosis.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Lesser-known myelin-related disorders: Focal tumour-like demyelinating lesions.
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.
Thy28 protects against anti-CD3-mediated thymic cell death in vivo.
Neural correlates of episodic future thinking impairment in multiple sclerosis patients.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Omega-3 prevents myelin degeneration in rat foetuses exposed to radiation.
Widespread synaptic loss in multiple sclerosis.
MAIT cells in autoimmunity, immune mediated diseases and airways disease.
A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of >10 years in multi-ethnic Penang, Malaysia: Clinical features and disease course.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
Pages
« first
‹ previous
…
645
646
647
648
649
650
651
652
653
…
next ›
last »